查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1547636

全球临床试验用品市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Clinical Trial Supplies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

全球临床试验用品市场需求预计将从 2023 年的 31.1 亿美元达到 2032 年近 57.3 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 7.02%。

临床试验用品是指用于测试研究药物、医疗器材或治疗介入措施在人类受试者中的安全性、有效性和耐受性的材料、设备和药品。这些用品包括研究药物或安慰剂製剂、医疗器材、生物标本、实验室试剂以及根据监管指南和研究方案进行临床试验所需的研究文件。临床研究组织 (CRO)、製药公司或研究机构对这些数据进行精心管理和分发，以确保遵守良好临床实践 (GCP) 标准以及临床试验期间收集的研究资料的完整性。

市场动态

推动临床试验用品市场的因素包括临床试验数量的增加、临床研究的全球化以及对专业临床试验服务的需求。此外，临床试验的复杂性和范围不断扩大，特别是在肿瘤学、罕见疾病和生物製剂等治疗领域，推动了对专业临床试验用品和物流解决方案的需求。此外，临床研究的全球化以及将临床试验网路扩展到新兴市场推动了对高效、合规的供应链管理解决方案的需求，以确保及时交付和监管合规性。此外，在 COVID-19 大流行的推动下，虚拟和去中心化临床试验模式的日益普及推动了临床试验供应管理技术和服务的创新。临床试验实施和产品品质标准的监管要求也推动了市场的发展，推动了对品质保证和监管合规措施的投资。然而，严格的法规和后勤挑战可能会阻碍未来几年临床试验用品市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球临床试验用品市场的每个细分市场进行包容性评估。临床试验用品产业的成长和趋势为这项研究提供了整体方法。

市场区隔

临床试验用品市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按临床阶段

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 其他

按产品和服务

  • 製造业
  • 仓储及配送（冷链配送、非冷链）
  • 供应链管理

按最终用途

  • 製药
  • 生物製剂
  • 医疗器材
  • 其他的

按治疗用途

  • 肿瘤学
  • 中枢神经系统
  • 心血管
  • 传染病
  • 代谢紊乱
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲临床试验用品市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。临床试验用品市场的主要参与者包括 Almac Group、Biocair、Catalent Inc.、KLIFO、Movianto、PCI Pharma Services、Sharp Services LLC、Thermo Fischer Scientific Inc.、Marken、Parexel International Corporation。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：临床试验用品 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按临床阶段分類的市场吸引力分析
    • 按产品和服务分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 按治疗用途进行的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球临床试验用品市场分析：依临床阶段分类

  • 按临床阶段概述
  • 历史和预测数据
  • 按临床阶段分析
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 其他

第 6 章：全球临床试验用品市场分析：依产品与服务分类

  • 按产品和服务分類的概述
  • 历史和预测数据
  • 按产品和服务分析
  • 製造业
  • 仓储及配送（冷链配送、非冷链）
  • 供应链管理

第 7 章：全球临床试验用品市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 历史和预测数据
  • 按最终用途分析
  • 製药
  • 生物製剂
  • 医疗器材
  • 其他的

第 8 章：全球临床试验用品市场分析：依治疗用途

  • 按治疗用途概述
  • 历史和预测数据
  • 按治疗用途分析
  • 肿瘤学
  • 中枢神经系统
  • 心血管
  • 传染病
  • 代谢紊乱
  • 其他的

第 9 章：全球临床试验用品市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：临床试验用品公司的竞争格局

  • 临床试验用品市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Almac Group
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Biocair
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Catalent Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • KLIFO
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Movianto
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • PCI Pharma Services
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sharp Services LLC
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fischer Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Marken
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Parexel International Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11214170

The global demand for Clinical Trial Supplies Market is presumed to reach the market size of nearly USD 5.73 Billion by 2032 from USD 3.11 Billion in 2023 with a CAGR of 7.02% under the study period 2024-2032.

Clinical trial supplies refer to the materials, equipment, and pharmaceutical products used to test the safety, efficacy, and tolerability of investigational drugs, medical devices, or therapeutic interventions in human subjects. These supplies include investigational drugs or placebo formulations, medical devices, biological specimens, laboratory reagents, and study documentation required for conducting clinical trials according to regulatory guidelines and study protocols. Clinical research organizations (CROs), pharmaceutical companies, or research institutions meticulously managed and distributed these to guarantee adherence to good clinical practice (GCP) standards and the integrity of study data collected during clinical trials.

MARKET DYNAMICS

The factors fuelling the clinical trial supplies market include the increasing number of clinical trials, the globalization of clinical research, and the demand for specialized clinical trial services. Moreover, the growing complexity and scope of clinical trials, particularly in therapeutic areas such as oncology, rare diseases, and biologics, drive the demand for specialized clinical trial supplies and logistics solutions. Additionally, the globalization of clinical research and expanding clinical trial networks into emerging markets drive the need for efficient and compliant supply chain management solutions that ensure timely delivery and regulatory compliance. Furthermore, the increasing adoption of virtual and decentralized clinical trial models, accelerated by the COVID-19 pandemic, drives innovation in clinical trial supply management technologies and services. The market is also fuelled by regulatory requirements governing clinical trial conduct and product quality standards, driving investment in quality assurance and regulatory compliance measures. However, stringent regulations and logistical challenges may hinder the clinical trial supplies market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Clinical Trial Supplies. The growth and trends of Clinical Trial Supplies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Clinical Trial Supplies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Clinical Phase

  • Phase I
  • Phase II
  • Phase III
  • Other

By Product & Services

  • Manufacturing
  • Storage & Distribution (Cold Chain Distribution, Non-Cold Chain)
  • Supply Chain Management

By End-use

  • Pharmaceutical
  • Biologics
  • Medical Device
  • Others

By Therapeutic Use

  • Oncology
  • CNS
  • Cardiovascular
  • Infectious Disease
  • Metabolic Disorders
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Trial Supplies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Trial Supplies market include Almac Group, Biocair, Catalent Inc., KLIFO, Movianto, PCI Pharma Services, Sharp Services LLC, Thermo Fischer Scientific Inc., Marken, Parexel International Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CLINICAL TRIAL SUPPLIES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Clinical Phase
    • 3.7.2 Market Attractiveness Analysis By Product & Services
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Therapeutic Use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET ANALYSIS BY CLINICAL PHASE

  • 5.1. Overview By Clinical Phase
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Clinical Phase
  • 5.4. Phase I Historic and Forecast Sales By Regions
  • 5.5. Phase II Historic and Forecast Sales By Regions
  • 5.6. Phase III Historic and Forecast Sales By Regions
  • 5.7. Other Historic and Forecast Sales By Regions

6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET ANALYSIS BY PRODUCT & SERVICES

  • 6.1. Overview By Product & Services
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Product & Services
  • 6.4. Manufacturing Historic and Forecast Sales By Regions
  • 6.5. Storage & Distribution (Cold Chain Distribution, Non-Cold Chain) Historic and Forecast Sales By Regions
  • 6.6. Supply Chain Management Historic and Forecast Sales By Regions

7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By End-use
  • 7.4. Pharmaceutical Historic and Forecast Sales By Regions
  • 7.5. Biologics Historic and Forecast Sales By Regions
  • 7.6. Medical Device Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET ANALYSIS BY THERAPEUTIC USE

  • 8.1. Overview By Therapeutic Use
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Therapeutic Use
  • 8.4. Oncology Historic and Forecast Sales By Regions
  • 8.5. CNS Historic and Forecast Sales By Regions
  • 8.6. Cardiovascular Historic and Forecast Sales By Regions
  • 8.7. Infectious Disease Historic and Forecast Sales By Regions
  • 8.8. Metabolic Disorders Historic and Forecast Sales By Regions
  • 8.9. Others Historic and Forecast Sales By Regions

9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CLINICAL TRIAL SUPPLIES COMPANIES

  • 10.1. Clinical Trial Supplies Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF CLINICAL TRIAL SUPPLIES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Almac Group
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Biocair
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Catalent Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. KLIFO
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Movianto
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. PCI Pharma Services
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Sharp Services LLC
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Thermo Fischer Scientific Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Marken
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Parexel International Corporation
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Clinical Phase (USD MN)
  • Phase I Market Sales By Geography (USD MN)
  • Phase II Market Sales By Geography (USD MN)
  • Phase III Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Product & Services (USD MN)
  • Manufacturing Market Sales By Geography (USD MN)
  • Storage & Distribution (Cold Chain Distribution, Non-Cold Chain) Market Sales By Geography (USD MN)
  • Supply Chain Management Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Pharmaceutical Market Sales By Geography (USD MN)
  • Biologics Market Sales By Geography (USD MN)
  • Medical Device Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Therapeutic Use (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • CNS Market Sales By Geography (USD MN)
  • Cardiovascular Market Sales By Geography (USD MN)
  • Infectious Disease Market Sales By Geography (USD MN)
  • Metabolic Disorders Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Clinical Trial Supplies Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Clinical Trial Supplies Report
  • Market Research Process
  • Market Research Methodology
  • Global Clinical Trial Supplies Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Clinical Phase
  • Market Attractiveness Analysis By Product & Services
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Therapeutic Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Clinical Phase (USD MN)
  • Phase I Market Sales By Geography (USD MN)
  • Phase II Market Sales By Geography (USD MN)
  • Phase III Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Product & Services (USD MN)
  • Manufacturing Market Sales By Geography (USD MN)
  • Storage & Distribution (Cold Chain Distribution, Non-Cold Chain) Market Sales By Geography (USD MN)
  • Supply Chain Management Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Pharmaceutical Market Sales By Geography (USD MN)
  • Biologics Market Sales By Geography (USD MN)
  • Medical Device Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapeutic Use (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • CNS Market Sales By Geography (USD MN)
  • Cardiovascular Market Sales By Geography (USD MN)
  • Infectious Disease Market Sales By Geography (USD MN)
  • Metabolic Disorders Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.